A Study to Evaluate the Effects of YM872 on Stroke Lesion Volume in Acute Stroke Patients
Study Details
Study Description
Brief Summary
This study will investigate the effects of a potential neuroprotectant compound, YM872, in the treatment of acute ischemic stroke. The study will determine if a 24-hour infusion of YM872, given within 6 hours of stroke onset, reduces the ischemic lesion volume as measured by MRI at 28 days after the infusion is given. The clinical effects of YM872 will also be determined by neurological function and disability scores at follow up visits through Day 90 of the study.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 2 |
Study Design
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients who have suffered an acute ischemic stroke and can be evaluated and treatment initiated within 6 hours after the onset of symptoms (Onset is defined as the time that which the patient was last seen in a normal state, or bedtime for unwitnessed strokes occurring during the night).
-
Patients who have a three dimensionally measurable lesion compatible with an acute ischemic stroke measured using MRI.
-
Patients who have a National Institutes of Health Stroke Scale (NIHSS) score of at least 7 but not more than 23 and who are conscious.
-
Patients who are able to provide written informed consent or have consent provided by a legally authorized representative.
-
Patients who are at least 18 years of age.
-
Other criteria as specified in the study protocol
Exclusion Criteria:
-
Patients who have received alteplase (t-PA) for the current stroke episode. It is assumed that all patients who are eligible will receive treatment with t-PA.
-
Patients who have disability and functional limitations prior to the current stroke episode (e.g. deficit resulting from a prior stroke).
-
Patients who have brain hemorrhage.
-
Patients who have stroke of the brainstem or cerebellum.
-
Patients who cannot be evaluated using MRI due to the presence of a pacemaker, claustrophobia, need for sedation, etc.
-
Patients who have renal (kidney) disease or insufficiency.
-
Patients who have active epilepsy or convulsions during the current stroke episode.
-
Patients who are IV drug users or are inebriated.
-
Patients who have a history of drug-related anaphylaxis.
-
Patients who have taken sedatives, anticonvulsants, or any medication with sedating effects in the 10 days prior study enrollment.
-
Patients who have taken more than 1.3 g of aspirin per day in the 2 days prior to enrollment.
-
Patients who have a known vitamin hypersensitivity.
-
Other exclusion criteria as specified by the study protocol.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of South Alabama Stroke Center | Mobile | Alabama | United States | |
2 | Phoenix Neurology Associates (Good Samaritan Hospital) | Phoenix | Arizona | United States | |
3 | University of Arizona | Tucson | Arizona | United States | |
4 | Providence St. Joseph's Medical Center | Burbank | California | United States | |
5 | Grossmont Hospital | La Mesa | California | United States | |
6 | UCLA Emergency Medical Center | Los Angeles | California | United States | |
7 | Good Samaritan Hospital | San Jose | California | United States | |
8 | Santa Monica UCLA Medical Center | Santa Monica | California | United States | |
9 | John Muir Medical Center | Walnut Creek | California | United States | |
10 | Bridgeport Hospital | Bridgeport | Connecticut | United States | |
11 | Bethesda Memorial Hospital | Boynton Beach | Florida | United States | |
12 | Holmes Regional Medical Center | Melbourne | Florida | United States | |
13 | University of Miami (Jackson Memorial Hospital) | Miami | Florida | United States | |
14 | Florida Neurovascular Institute | Tampa | Florida | United States | |
15 | DNA Research (Dekalb Medical Center) | Decatur | Georgia | United States | |
16 | OSF St. Francis Medical Center | Peoria | Illinois | United States | |
17 | Parkview Hospital | Fort Wayne | Indiana | United States | |
18 | University of Kentucky | Lexington | Kentucky | United States | |
19 | Louisville Neuroscience Research Center | Louisville | Kentucky | United States | |
20 | Cullicchia Neurology Clinic, LLP | Marrero | Louisiana | United States | |
21 | Johns Hopkins Medical Institute | Baltimore | Maryland | United States | |
22 | Beth Israel Deaconess Medical Center | Boston | Massachusetts | United States | |
23 | New England Medical Center | Boston | Massachusetts | United States | |
24 | Wayne State University | Detroit | Michigan | United States | |
25 | Michigan State University | East Lansing | Michigan | United States | |
26 | William Beaumont Hospital | Royal Oak | Michigan | United States | |
27 | Field Neurosciences Institute (St. Mary's Hospital) | Saginaw | Michigan | United States | |
28 | Advanced Neurology Specialists (Benefis Healthcare Hospital) | Great Falls | Montana | United States | |
29 | St. Patrick's Hospital & Health Sciences Center | Missoula | Montana | United States | |
30 | Washoe Comprehensive Stroke Center | Reno | Nevada | United States | |
31 | JFK Medical Center | Edison | New Jersey | United States | |
32 | Neurology Group of Bergen County (Valley Hospital) | Ridgewood | New Jersey | United States | |
33 | University of New Mexico Hospital | Albuquerque | New Mexico | United States | |
34 | VA Medical Center | Albuquerque | New Mexico | United States | |
35 | Albany Medical Center | Albany | New York | United States | |
36 | Buffalo General Hospital | Buffalo | New York | United States | |
37 | North Shore University Hospital | Manhasset | New York | United States | |
38 | Long Island Jewish Medical Center | New Hyde Park | New York | United States | |
39 | St. Luke's Hospital | New York | New York | United States | |
40 | Ellis Hospital | Schenectady | New York | United States | |
41 | Stony Brook Hospital | Stony Brook | New York | United States | |
42 | All-Trials Clinical Research, LLC (Rowan Regional Medical Center) | Winston-Salem | North Carolina | United States | |
43 | Metrohealth Medical Center | Cleveland | Ohio | United States | |
44 | Riverside Methodist Hospital | Columbus | Ohio | United States | |
45 | Medical College of Ohio | Toledo | Ohio | United States | |
46 | St. Elizabeth Health Center | Youngstown | Ohio | United States | |
47 | Hershey Medical Center | Hershey | Pennsylvania | United States | |
48 | University of Pittsburgh Medical Center Stroke Institute | Pittsburgh | Pennsylvania | United States | |
49 | Chattanooga Neurology Associates (Erlanger Hospital) | Chattanooga | Tennessee | United States | |
50 | Chattanooga Neurology Associates (Memorial Hospital) | Chattanooga | Tennessee | United States | |
51 | St. Thomas Hospital | Nashville | Tennessee | United States | |
52 | Vanderbilt University Medical Center | Nashville | Tennessee | United States | |
53 | University of Texas (Houston Medical Center) | Houston | Texas | United States | |
54 | Neurology Associates, Inc. (St. Mary's Hospital) | Richmond | Virginia | United States | |
55 | Virginia Beach General Hospital | Virginia Beach | Virginia | United States | |
56 | Stevens Memorial Hospital | Edmonds | Washington | United States | |
57 | Providence St. Peter Hospital | Olympia | Washington | United States | |
58 | Sacred Heart Medical Center | Spokane | Washington | United States | |
59 | St. Luke's Medical Center | Milwaukee | Wisconsin | United States | |
60 | Theda Clark Medical Center | Neenah | Wisconsin | United States | |
61 | Universitätsklinik Allgemeines | Wien | Austria | ||
62 | Hopital Erasme | Brussels | Belgium | ||
63 | Service de Neurologie, Cliniques Universitaires St.-Luc | Bruxelles | Belgium | ||
64 | Dienst Neurologie UZ Gasthuisberg | Leuven | Belgium | ||
65 | University of Alberta Hospital | Edmonton | Alberta | Canada | |
66 | Royal Jubilee Hospital | Victoria | British Columbia | Canada | |
67 | Toronto Western Hospital | Toronto | Ontario | Canada | |
68 | Universitätsklinikum Aachen, Neurologische Klinik | Aachen | Germany | ||
69 | University of Essen | Essen | Germany | ||
70 | Neurologische Universitätsklinik, Albert-Ludwigs-University | Freiburg | Germany | ||
71 | Universitätskrankenhaus Hamburg-Eppendorf Klinik für Neurologie | Hamburg-Eppendorf | Germany | ||
72 | Universitatklinikum Homburg, Neurologie Klinik und Poliklinik | Homburg Saar | Germany | ||
73 | Friedrich-Schiller-University | Jena | Germany | ||
74 | Universität zu Köln klinik und poliklinik fur neurology | Koln | Germany | ||
75 | Universitatklinikum Leipzig | Leipzig | Germany | ||
76 | Universitätsklinik Mainz | Mainz | Germany | ||
77 | Department of Neurology Klinikum | Minden | Germany | ||
78 | Neurologische Klinik Klinikum Rechts der Isar der TU Munchen | Munchen | Germany | ||
79 | Neurologische Klinik Knappschafts - krankenhause | Recklinghausen | Germany | ||
80 | Dr.-H.-Schmidt-Kliniken Ludwig-Erhar | Wiesbaden | Germany | ||
81 | Muelmed Hospital | Arcadia | South Africa | ||
82 | Bloemfontein Medi-Clinic | Bloemfontein | South Africa | ||
83 | Groote Schuur Hospital | Cape Town | South Africa | ||
84 | St. Augustine's Hospital | Durban | South Africa | ||
85 | Sandton Medi-Clinic | Johannesburg | South Africa | ||
86 | Pietermaritzburg Medi-Clinic | Pietermaritzburg | South Africa | ||
87 | Little Company of Mary Medical Centre | Pretoria | South Africa | ||
88 | Vergelegen Medi-Clinic | Somerset West | South Africa | ||
89 | Sunninghill Hospital | Sunninghill | South Africa |
Sponsors and Collaborators
- Astellas Pharma Inc
- Astellas Pharma US, Inc.
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 872-CL-003